Antimicrobial Peptides SET-M33L and SET-M33L-PEG Are Promising Agents Against Strong Biofilm-Forming <i>P. aeruginosa</i>, Including Multidrug-Resistant Isolates
<b>Background</b>: The antimicrobial peptides (AMPs) SET-M33L and SET-M33L-PEG were investigated against 10 clinical isolates of <i>P. aeruginosa</i>. <b>Methods</b>: Their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and m...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/14/7/699 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | <b>Background</b>: The antimicrobial peptides (AMPs) SET-M33L and SET-M33L-PEG were investigated against 10 clinical isolates of <i>P. aeruginosa</i>. <b>Methods</b>: Their minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), and minimum biofilm inhibitory concentrations (MBICs) were evaluated against tobramycin, ceftazidime, and polymyxin B. <b>Results</b>: MICs and MBCs were 7- to 100-fold lower than tobramycin, and 10- to 300-fold lower than ceftazidime. Fractional inhibitory concentration (FIC) indices showed an additive effect, while fractional bactericidal concentration (FBC) indices showed synergistic effects (FBC < 0.5) for most isolates. <b>Conclusion</b>: SET-M33L and SET-M33L-PEG are promising antimicrobial agents against strong biofilm-forming <i>P. aeruginosa</i>, including MDR isolates. |
---|---|
ISSN: | 2079-6382 |